相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo
Yun Dai et al.
BLOOD (2011)
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2
Xin-Yan Pei et al.
BLOOD (2011)
Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death
Clint Mitchell et al.
CANCER BIOLOGY & THERAPY (2011)
Glioblastoma multiforme with an unusual location and clinical course
É. Gömöri et al.
CLINICAL NEUROPATHOLOGY (2011)
CHK1 Inhibitors in Combination Chemotherapy Thinking Beyond the Cell Cycle
Paul Dent et al.
MOLECULAR INTERVENTIONS (2011)
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
Cynthia X. Ma et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
Clint Mitchell et al.
CANCER BIOLOGY & THERAPY (2010)
Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways
Fan Yang et al.
MOLECULAR CANCER RESEARCH (2010)
Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
Clint Mitchell et al.
MOLECULAR PHARMACOLOGY (2010)
Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma
Hossein A. Hamed et al.
MOLECULAR THERAPY (2010)
Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach
R. Rockne et al.
PHYSICS IN MEDICINE AND BIOLOGY (2010)
Glioblastoma multiforme: a review of where we have been and where we are going
Cory Adamson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Glioblastoma multiforme: a review of therapeutic targets
Okezie O. Kanu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
Aditi Pandya Martin et al.
MOLECULAR PHARMACOLOGY (2009)
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells
Yun Dai et al.
BLOOD (2008)
DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy
Susan Ashwell et al.
CLINICAL CANCER RESEARCH (2008)
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells
Adly Yacoub et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling
Adly Yacoub et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo
Hossein Hamed et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
Fan Yang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism
Xin-Yan Pei et al.
BLOOD (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2
Luigi Carlessi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Activated checkpoint kinase 2 provides a survival signal for tumor cells
Jagadish C. Ghosh et al.
CANCER RESEARCH (2006)
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cells
Xin-Yan Pei et al.
MOLECULAR PHARMACOLOGY (2006)
An intrinsic cell cycle checkpoint pathway mediated by MEK and ERK in Drosophila
Vladic Mogila et al.
DEVELOPMENTAL CELL (2006)
The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment
Meredith A. Morgan et al.
CELL CYCLE (2006)
Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining
J Zhuang et al.
CANCER RESEARCH (2006)
Chk1 is essential for tumor cell viability following activation of the replication checkpoint
SH Cho et al.
CELL CYCLE (2005)
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells
A Yacoub et al.
CANCER BIOLOGY & THERAPY (2004)
mda-7 (IL-24) inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling
A Yacoub et al.
CANCER BIOLOGY & THERAPY (2003)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints
H Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism
Y Dai et al.
BLOOD (2002)
The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation
KW Eley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells
R McKinstry et al.
CANCER BIOLOGY & THERAPY (2002)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
A comparison of treatment results for recurrent malignant gliomas
C Nieder et al.
CANCER TREATMENT REVIEWS (2000)
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-xL in response to DNA damage
S Kharbanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)